Publication | Closed Access

Age at cancer diagnosis, non-O blood group and asparaginase therapy are independently associated with deep venous thrombosis in pediatric oncology patients: A risk model

ThrombosisDeep Venous ThrombosisVenous DiseaseOncologyRisk ModelVenous ThrombosisVenous Disease TreatmentHematologyPediatricsCoagulopathyPediatric OncologyNon-o Blood GroupMedicineCancer Research